Scarica l'app Stockscreener
27.37
1.07%
0.29
Dopo l'orario di chiusura:
27.34
-0.03
-0.11%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PFE Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Pfizer Inc Borsa (PFE) Ultime notizie
Pfizer (PFE) Stands Out as Top Big Pharma Pick - GuruFocus
Trump unveils TrumpRx; Pfizer to offer discounted drugs after 100% tariff threat - CBS News
3 Dirt Cheap Stocks to Buy in a Market Priced for Perfection - The Globe and Mail
Is Pfizer Inc. (PFE) the Best Non-Tech Stock to Buy Now for Long Term? - MSN
Can Pfizer's Stock Break This Disappointing Streak? - AOL.com
Bank of America Securities Maintains Buy on Pfizer Inc (PFE) - Yahoo Finance
President Trump was undaunted getting Pfizer deal: Dr. Oz - NewsNation
ThinkCareBelieve: Week 37 America Isn’t Stopping - GlobeNewswire Inc.
Pfizer (PFE) Surges Following Landmark Drug Pricing Deal - GuruFocus
Pfizer – TrumpRx deal boosts Big Pharma to a record rally - Seeking Alpha
Pfizer’s AI Revolution: A New Era for Drug Discovery and Pharmaceutical Innovation - FinancialContent
Tech stocks roll on and Pfizer soars after Trump deal - Yahoo Finance
Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know - sharewise.com
5 Large Cap Drug Stocks: Values or Traps? - The Globe and Mail
The Score: Pfizer, Tesla, Electronic Arts and More Stocks That Defined the Week - MSN
B of A Securities Maintains Pfizer (PFE) Neutral Recommendation - Nasdaq
Pharma Stocks Eye Best Week in 16 Years as Trump Overhang Eases - Bloomberg.com
Wall Street Hits Record Highs As Rate Cut Bets Offset Shutdown: This Week In MarketsPfizer (NYSE:PFE) - Benzinga
What TrumpRx Means for Pfizer Stock and Pharma Investors - Stansberry Research
How Trump’s 100% Tariff Threat Forced Pfizer’s Hand — Inside The High-Stakes Talks That Changed Big Pharma’s Course - Stocktwits
Pfizer (PFE) Experiences Bullish Activity as Options Volume Surges - GuruFocus
Gallego demands transparency in Trump’s deal with Pfizer - The Hill
Trump administration announces MFN drug pricing deal with Pfizer - Yahoo Finance
Pink Sheet Podcast: Government Shutdown’s Impact On US FDA, Pfizer Inks Drug Pricing Deal - insights.citeline.com
Is PFE Stock a Buy After 14% Rise Post Drug Pricing Deal With Trump? - The Globe and Mail
MRK Stock Up Nearly 14% So Far This Week: What's Driving It? - The Globe and Mail
Pfizer’s drug-price deal with Trump ended months of deadlock - The Edge Malaysia
Weekly Rundown: TrumpRx unveils direct-to-consumer platform, Pfizer on board - Drug Discovery News
Pfizer (PFE) Is Up 14.7% After Landmark U.S. Drug Pricing and Tariff Exemption Deal - Yahoo Finance
Shareholders 26% loss in Pfizer (NYSE:PFE) partly attributable to the company's decline in earnings over past three years - Yahoo Finance
How Trump Finally Cut a Deal With Big Pharma - Bloomberg.com
Pfizer (PFE) Secures Deal to Avert Tariffs Through U.S. Manufact - GuruFocus
Cantor Fitzgerald Maintains a Hold on Pfizer (PFE) - Yahoo Finance
MAHA supporters not on board with Trump’s Pfizer deal - The Hill
Eli Lilly And Its Competitors Pop On The Pfizer News - Real Investment Advice
Pfizer (PFE): Evaluating Valuation After Breakthrough U.S. Drug Pricing Deal Spurs Market Optimism - simplywall.st
Pfizer Just Made a Landmark Drug Pricing Agreement with President Donald Trump. Is the Stock a Buy? - Yahoo Finance
Pfizer’s Drug-Price Deal With Trump Followed Months of Deadlock - Bloomberg Law News
Exclusive | Inside Pfizer’s Drug-Pricing Deal With the Trump Administration - The Wall Street Journal
Inside Pfizer’s Drug-Pricing Deal With the Trump Administration - The Wall Street Journal
Pfizer Finally Gave Trump What He Wanted - AOL.com
FDA head says Trump-Pfizer deal to lower prescription drug costs is "major step" - CBS News
Health Care Down, Paring Gains From Pfizer Deal -- Health Care Roundup - MarketScreener
Trump administration pauses 100% import tax on drugs amid Pfizer negotiations - 13wham.com
Cartography Bio maps out cancer drug plan with $67 million from Pfizer, Amgen venture units and more - The Business Journals
September Social Media Round-Up—Fast Company, Prostate Cancer Awareness Month, and More - Pfizer
View / Pfizer’s Oval Office show is the new face of pre-regulation - https-//www.semafor.com
How TrumpRx Website May Affect Your Drug Costs After Pfizer Deal - The New York Times
Pfizer Goes All In On TrumpRx. Is Pfizer Stock Now A Buy? - Investor's Business Daily
Pfizer Reaches Pricing Agreement With Trump Administration - Contract Pharma
Pfizer: The Long Suffering Is Finally Over (Rating Upgrade) (NYSE:PFE) - Seeking Alpha
Pfizer Stock, Other Drugmakers Rally Again - The Wall Street Journal
Why Pfizer’s Trump Deal Is Good News for All of Big Pharma - The Wall Street Journal
Procter & Gamble Will Shut Down Business in Pakistan, Following Shell and Pfizer Exits - MSN
SHASQI STRENGTHENS BOARD OF DIRECTORS WITH THE APPOINTMENT OF FORMER CHIEF DEVELOPMENT OFFICER AT PFIZER ONCOLOGY - BioSpace
Procter & Gamble will shut down business in Pakistan, following Shell and Pfizer exits - The Economic Times
BMO Capital Maintains Outperform on Pfizer (PFE) Amid New Obesity Partnership - Yahoo Finance
0.16%
0.36%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):